yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33600072-D8BE5864-F765-4898-825B-F35109E8C08F
Q33600072-D8BE5864-F765-4898-825B-F35109E8C08F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33600072-D8BE5864-F765-4898-825B-F35109E8C08F
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
P2860
Q33600072-D8BE5864-F765-4898-825B-F35109E8C08F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33600072-D8BE5864-F765-4898-825B-F35109E8C08F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a13c427c32f2f949687f51b8ae36464a79482de
P2860
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.